1995
DOI: 10.1111/j.1476-5381.1995.tb13285.x
|View full text |Cite
|
Sign up to set email alerts
|

Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
55
2
4

Year Published

2001
2001
2016
2016

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 86 publications
(67 citation statements)
references
References 41 publications
6
55
2
4
Order By: Relevance
“…We attempted to address this issue by using two different inhibitors known to disrupt the kinases involved in insulin signaling. Our findings with isolated perifused rat islets confirm the observations made using mouse islets (38) or neonatal cultured rat islets (39): genistein is a potentiator of glucose-induced secretion. Furthermore, our findings also confirm previous studies in both rat (23,40) and mouse (41) islets as well as in MIN cells (42); wortmannin is a potentiator of glucose-induced secretion.…”
Section: Discussionsupporting
confidence: 80%
See 1 more Smart Citation
“…We attempted to address this issue by using two different inhibitors known to disrupt the kinases involved in insulin signaling. Our findings with isolated perifused rat islets confirm the observations made using mouse islets (38) or neonatal cultured rat islets (39): genistein is a potentiator of glucose-induced secretion. Furthermore, our findings also confirm previous studies in both rat (23,40) and mouse (41) islets as well as in MIN cells (42); wortmannin is a potentiator of glucose-induced secretion.…”
Section: Discussionsupporting
confidence: 80%
“…Our studies, as well as those of others, using pharmacologic inhibition of the kinase involved with insulin signaling are also consistent with the hypothesis that constitutive insulin signaling acts to restrain stimulated insulin secretion. For example, neither wortmannin nor genistein potentiates release from islets in the presence of low nonstimulatory glucose (23,38). Their positive effect on secretion only becomes manifest when stimulatory glucose is employed.…”
Section: Discussionmentioning
confidence: 99%
“…Similar nonspecificity has been seen on other parameters when using a range of other tyrosine kinase inhibitors in islet cells (32). We therefore turned to the converse approach of using sodium orthovanadate, a tyrosine phosphatase inhibitor that augments tyrosine phosphorylation of several islet cell proteins (Ref.…”
Section: Resultsmentioning
confidence: 99%
“…3, lanes 1, 7, and 10, top and bottom panels; Fig. 4, lanes 1, 3, 5, 7, and 9 of the left panel and lanes 1,5,7, and 9 of the right panel).…”
Section: Resultsmentioning
confidence: 99%
“…The top and bottom panels each show a separate experiment. Samples in lanes 13 and 14 contained methanol equal to that in samples applied to lanes [5][6][7][8][9][10][11][12]. The concentration of Q 1 and Q 2 was 1 mM except in mixtures shown in lanes 9, 11, and 12 of the bottom panel, where the concentration of Q 2 was 0.5 mM.…”
Section: Figmentioning
confidence: 99%